Neuvivo makes bid to enter ALS arena with immunotherapy candidate
NP001 is designed to tackle the neurodegenerative disease through an immunologic mechanism as opposed to a neurologic one.
NP001 is designed to tackle the neurodegenerative disease through an immunologic mechanism as opposed to a neurologic one.
What's Your Reaction?
